Create Account | Sign In: Author or Forum

Search Symptoms

Category: Oncology | ENT | Psychiatry | Journal

Back to Journal Articles

Mental Health Disorders Up After Head & Neck Cancer Diagnosis

Last Updated: February 28, 2019.

In patients with head and neck cancer, the prevalence of mental health disorders is significantly higher after cancer diagnosis, according to a study published online Feb. 28 in JAMA Otolaryngology-Head & Neck Surgery.

THURSDAY, Feb. 28, 2019 (HealthDay News) -- In patients with head and neck cancer (HNC), the prevalence of mental health disorders (MHDs) is significantly higher after cancer diagnosis, according to a study published online Feb. 28 in JAMA Otolaryngology-Head & Neck Surgery.

Ji Hyae Lee, from Pennsylvania State University in Hershey, and colleagues conducted a retrospective cohort study to describe the prevalence of MHDs in patients with HNC and the potential associations with survival and recurrence. Data were included for 52,641 patients with a diagnosis of HNC.

The researchers found that men, patients aged 55 to 64 years, and those from the South most commonly had HNC (58.5, 46.6, and 40.3 percent). Oral cavity cancers were the most common type of cancer (40.4 percent), followed by cancers of the oropharynx and larynx (19.2 and 15.5 percent, respectively). Patients with cancers of the trachea versus the oral cavity had a significantly increased odds ratio for MHD prevalence (2.11). In patients with HNC, the prevalence of MHDs increased to 29.9 percent compared with 20.6 percent before the cancer diagnosis. After the diagnosis of HNC, women and patients with a history of tobacco use and alcohol use had significantly higher odds of MHDs (adjusted odds ratios, 1.58, 1.42, and 1.56, respectively).

"Individualized care may help recognize and address the sociodemographic variables affecting mental health of the patients with HNC," the authors write.

Two authors disclosed financial ties to the medical device industry.

Abstract/Full Text (subscription or payment may be required)


Previous: Teens’ Social Media Use Does Not Predict Later Depression Next: FDA: Pulmonary Embolism Risk Up With Tofacitinib 10 mg for RA

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion: